VEGF-C and COX-2 in Breast Cancer and Lymphangiogenesis
Author Information
Author(s): Zhang Xiao-Hua, Huang Du-Ping, Guo Gui-Long, Chen Guo-Rong, Zhang Hu-Xiang, Wan Li, Chen Sheng-Ying
Primary Institution: The First Affiliated Hospital of Wenzhou Medical College
Hypothesis
The study investigates the relationship between VEGF-C and COX-2 in human breast cancer and their correlations with lymphangiogenesis and prognosis.
Conclusion
COX-2 and VEGF-C are coexpressed and significantly associated with lymphangiogenesis and prognosis in invasive breast cancer.
Supporting Evidence
- High VEGF-C expression was observed in 42.8% of tumor samples.
- High COX-2 expression occurred in 65.7% of tumor samples.
- Elevated VEGF-C and COX-2 expressions were associated with higher lymph vessel density and worse survival outcomes.
Takeaway
This study found that two proteins, VEGF-C and COX-2, work together in breast cancer to help tumors spread through the lymphatic system.
Methodology
Tissue samples from 70 breast cancer patients were examined for VEGF-C, COX-2, and D2-40 expressions using immunohistochemistry.
Limitations
The study only included patients with unilateral, invasive breast cancer and excluded those with other malignancies or prior treatments.
Participant Demographics
Median age was 49 years, with 57.1% younger than 50 years and 45.7% having lymph node metastasis.
Statistical Information
P-Value
P < 0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website